PAROLARO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 13.949
EU - Europa 8.210
AS - Asia 3.860
SA - Sud America 567
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 26.653
Nazione #
US - Stati Uniti d'America 13.815
IT - Italia 4.132
UA - Ucraina 1.456
SG - Singapore 1.322
SE - Svezia 771
CN - Cina 650
TR - Turchia 630
VN - Vietnam 523
HK - Hong Kong 499
BR - Brasile 492
FI - Finlandia 380
IE - Irlanda 356
DE - Germania 351
GB - Regno Unito 269
RU - Federazione Russa 187
FR - Francia 106
CA - Canada 74
IN - India 54
JP - Giappone 54
MX - Messico 45
NL - Olanda 34
BD - Bangladesh 31
BE - Belgio 30
PL - Polonia 28
CZ - Repubblica Ceca 24
AR - Argentina 22
ZA - Sudafrica 21
ES - Italia 19
IQ - Iraq 17
AT - Austria 15
EU - Europa 15
VE - Venezuela 11
CO - Colombia 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
EC - Ecuador 9
PK - Pakistan 9
LT - Lituania 8
MA - Marocco 8
BG - Bulgaria 7
IL - Israele 7
MY - Malesia 7
AU - Australia 6
JO - Giordania 6
NP - Nepal 6
SA - Arabia Saudita 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
PT - Portogallo 5
UZ - Uzbekistan 5
CH - Svizzera 4
ID - Indonesia 4
PY - Paraguay 4
UY - Uruguay 4
AL - Albania 3
EG - Egitto 3
HU - Ungheria 3
KR - Corea 3
MD - Moldavia 3
PE - Perù 3
BO - Bolivia 2
CI - Costa d'Avorio 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BT - Bhutan 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
Totale 26.651
Città #
Milan 2.855
Fairfield 1.834
Woodbridge 1.128
Ashburn 1.126
Jacksonville 1.101
Chandler 1.089
Houston 837
Seattle 798
Wilmington 728
Singapore 709
Ann Arbor 659
Cambridge 607
Hong Kong 498
Dearborn 393
Princeton 380
Dublin 355
Izmir 352
Nyköping 349
Dallas 273
Rome 236
Boardman 224
Beijing 218
Dong Ket 218
Como 192
San Mateo 161
New York 147
The Dalles 144
Chicago 99
San Diego 89
Los Angeles 86
Ogden 61
Santa Clara 60
Washington 60
São Paulo 52
Tokyo 51
Hefei 50
London 46
Kunming 43
Munich 40
Norwalk 38
Ho Chi Minh City 36
Nanjing 34
Mexico City 33
Toronto 33
Brussels 30
Helsinki 29
Warsaw 28
Hanoi 24
Ponte Lambro 23
Brno 22
Brooklyn 21
Montreal 20
Nanchang 19
Verona 19
Guangzhou 18
Mcallen 18
Phoenix 18
Redwood City 18
Denver 17
Kocaeli 17
Atlanta 16
Berlin 16
Düsseldorf 16
Orem 16
Ankara 15
Chennai 15
Jinan 15
Johannesburg 15
Cagliari 14
Fuzhou 14
Stockholm 14
Falls Church 13
Nuremberg 13
Poplar 13
Carbonara Al Ticino 12
Edinburgh 12
Manchester 12
San Francisco 12
Amsterdam 11
Naples 11
Boston 10
Council Bluffs 10
Frankfurt am Main 10
Shanghai 9
Belo Horizonte 8
Chengdu 8
Istanbul 8
Ottawa 8
Paris 8
Redmond 8
Salt Lake City 8
Salvador 8
Shenyang 8
Varese 8
Wuhan 8
Benevento 7
Bologna 7
Brasília 7
Chongqing 7
Kilburn 7
Totale 19.300
Nome #
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 294
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 268
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 264
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 253
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 247
Assay of GTPγS binding in autoradiography 246
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 242
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 240
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 237
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 233
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 229
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 222
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 215
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 215
A molecular basis of analgesic tolerance to cannabinoids 211
MeCP2 related studies benefit from the use of CD1 as genetic background 211
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 210
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 209
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 207
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 207
New vistas on cannabis use disorder 204
Long lasting consequences of cannabis exposure in adolescence. 203
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi 200
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 199
Endocannabinoids and Mental Disorders. 195
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat 193
Cannabinoids and opioids share cAMP pathway in rat splenocytes 192
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 191
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 188
Role of endocannabinoids in regulating drug dependence 186
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 185
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 185
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor. 184
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 184
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 182
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 181
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 178
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 174
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche 174
Cannabinoids and Drugs of abuse 173
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 173
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 173
Expression and function of the endocannabinoid system in glial cells. 172
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 171
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 170
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 169
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 168
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 168
The endocannabinoid system and schizophrenia: integration of evidence. 167
Endocannabinoids and Drug Dependence 166
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 165
Molecular and cellular basis of cannabinoid and opioid interactions 163
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 162
The endocannabinoid system and psychiatric disorders. 162
Sex-dependent vulnerability to cannabis abuse in adolescence 162
Endocannabinoids in the immune system and cancer 161
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 160
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw 157
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 156
Neurobiological mechanisms underlying cannabis-induced memory impairment 155
The psychoactive ingredient of marijuana induces behavioural sensitization 153
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 153
Cannabidiol inhibits angiogenesis by multiple mechanisms 153
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 152
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 151
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 151
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects 151
A role of nitric oxide in WIN 55,212-2 tolerance in mice. 149
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system 148
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 147
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 147
Presence and functional regulation of cannabinoid receptors in immune cells 145
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 145
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 145
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 145
Cholera toxin effects on body temperature changes induced by morphine. 144
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat 143
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors 143
Binding studies of dermorphin and its L-form on rat brain opioid receptors. 142
Alterazioni cellulari e molecolari presenti nel sistema nervoso centrale durante i processi di sensitizzazione a lungo termine indotti da diversi farmaci d'abuso 141
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 140
Presence of a reduced opioid response in interleukin-6 knock out mice 140
Pertussis toxin inhibits the antinociceptive action of morphine in the rat.. 140
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats. 140
Cannabinoids as potential new therapy for the treatment of gliomas. 138
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 138
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat. 137
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 136
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. 136
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 136
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 133
Alterazioni cellulari indotte da farmaci d'abuso e da stimoli avversivi non evitabili nel sistema nervoso centrale di ratto 133
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 132
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine.. 132
null 132
Cannabinoids, immune system and cytokine network 131
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 131
Inhibition of tumor cell migration 131
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 131
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells 130
Totale 17.356
Categoria #
all - tutte 100.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.145 0 0 0 0 0 343 143 248 470 168 295 478
2021/20221.930 192 203 182 251 58 89 71 94 94 282 149 265
2022/20232.722 265 165 192 326 157 582 10 378 399 75 120 53
2023/20244.570 717 743 725 832 902 350 31 76 100 28 23 43
2024/20252.706 39 42 483 78 74 174 100 211 349 217 222 717
2025/20262.483 424 379 137 792 581 170 0 0 0 0 0 0
Totale 26.789